Dr. Reddy's Laboratories
Search results
5 days ago · Biocon develops affordable biosimilars, generic formulations and complex APIs for global markets. It also offers research services and novel biologics for various diseases.
- Careers
Careers - Biocon - India's largest biopharmaceutical company
- Contact Us
Biocon Limited 20th KM, Hosur Road, Electronic City,...
- Products
Biocon is addressing global medical needs through a...
- About Us
A global biopharmaceutical company changing patients’ lives...
- Investor Relations
Biocon is a unique global biopharmaceutical company changing...
- Businesses
Biocon’s business strategy of delivering affordable...
- Responsibility
Biocon academy, is a premier center of excellence for...
- Key Therapeutic Areas
At Biocon, our focus is on the three key therapeutic areas –...
- Careers
Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. [4] The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, [5] including the United States and Europe. [4]
A global biopharmaceutical company changing patients’ lives by finding new & affordable ways to treat diabetes, cancer & autoimmune diseases.
Biocon is a pioneer in biotechnology in India, with a mission to provide affordable and innovative medicines for diabetes, cancer and autoimmune diseases. It has four global businesses: generics, biosimilars, research services and novel biologics, and operates in over 120 countries.
1 day ago · Get the latest Biocon share price, stock performance, financials, news, analysis and recommendations from Economic Times. Biocon is a leading Indian biopharmaceutical company with a market cap of Rs 36,726.35 crore as of 18 May, 2024.
- As on 05 Jan, 2024, 04:04 PM IST Biocon share price was up by 2.71% basis the previous closing price of Rs 282.35. Biocon share price was Rs 291.30...
- Biocon share price saw a 52 week high of Rs 294.50 and 52 week low of Rs 191.55.
- Biocon share has a market capitalization of Rs 34,973.48 Cr. Within Pharmaceuticals sector, it's market cap rank is 13.
- Following are the key changes to Biocon shareholding: Promoter holding has not changed in last 9 months and holds 60.64 stake as on 30 Sep 2023 Dom...
- Key Metrics for Biocon are: PE Ratio of Biocon is 70.17 Earning per share of Biocon is 4.15 Price/Sales ratio of Biocon is 2.22 Price to Book ratio...
- Top 10 Peers for Biocon are Gland Pharma Ltd., Syngene International Ltd., Ipca Laboratories Ltd., Ajanta Pharma Ltd., J B Chemicals & Pharmaceutic...
4 days ago · Biocon announced that its Bengaluru mAbs facility has been approved by the European Medicines Agency (EMA) to manufacture biosimilar ‘Bevacizumab’. It is a type of targeted cancer drug treatment.
Get the latest Biocon Ltd (BIOCON) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
People also ask
Who is Biocon Limited?
Does Biocon own Syngene International?
Which Biocon products are available in India?
Who is Biocon Biopharmaceuticals?
When was Biocon founded?
Who owns Biocon pharmaceuticals?
